ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 21, 2020 |
Mar. 23, 2020 |
Jun. 30, 2022 |
Dec. 31, 2021 |
Jun. 30, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
Dec. 31, 2021 |
Dec. 31, 2020 |
May 18, 2022 |
Mar. 31, 2022 |
Mar. 03, 2022 |
|
| Research And Development Costs | $ 485,184 | $ 566,655 | $ 314,532 | $ 532,644 | $ 485,995 | $ 1,198,780 | $ 633,050 | |||||
| Ownership interest, percentage | 1.38% | 1.38% | 1.38% | 1.38% | 1.38% | |||||||
| Impairment Loss | $ 25,320,555 | $ 25,320,555 | ||||||||||
| Deferred Tax Asset | 4,129,000 | 2,830,000 | ||||||||||
| Advertising And Marketing Costs | $ 30,185 | 35,654 | $ 45,519 | 59,500 | $ 104,738 | $ 96,637 | ||||||
| Valuation Allowance, Percentage | 100.00% | 100.00% | 100.00% | |||||||||
| Common Stock, Shares Authorized | 100,000,000 | 100,000,000 | 100,000,000 | 100,000,000 | 100,000,000 | 7,917 | ||||||
| Common Stock, Par Value | $ 0.00001 | $ 0.00001 | $ 0.00001 | $ 0.00001 | $ 0.00001 | $ 0.00001 | $ 0.01 | |||||
| Loss From Operation | $ (1,671,368) | $ (1,314,688) | $ (4,430,386) | $ (2,281,702) | $ (5,555,234) | $ (28,269,589) | ||||||
| Property, Plant and Equipment [Member] | ||||||||||||
| Loss From Operation | $ (39,434) | $ (25,320,555) | $ (25,359,989) | |||||||||
| Annual Meeting of Shareholders [Member] | ||||||||||||
| Common Stock, Shares Authorized | 100,000,000 | 800,000,000 | 800,000,000 | |||||||||
| Common Stock, Par Value | $ 0.00001 | $ 0.00001 | $ 0.00001 | |||||||||
| Description Of Reverse Stock Split | The effective dates of the above actions were June 5, 2020 and April 20, 2020, respectively, and the actual reverse stock split ratio was 1-for-33.26 | reverse stock split of the Company’s outstanding common stock at a ratio between 1-for-32 and 1-for-35 (with the exact ratio to be determined by the directors in their sole discretion without further approval by the shareholders | ||||||||||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The total expense recognized in the period for promotion, public relations, and brand or product advertising. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The parent entity's interest in net assets of the subsidiary, expressed as a percentage. No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|